BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,145,940 | -24.7% | 796,089 | 0.0% | 2.05% | -29.4% |
Q2 2023 | $25,419,122 | +4.3% | 796,089 | 0.0% | 2.91% | +13.5% |
Q1 2023 | $24,376,245 | -21.7% | 796,089 | 0.0% | 2.56% | -18.8% |
Q4 2022 | $31,135,041 | -17.9% | 796,089 | 0.0% | 3.16% | -22.4% |
Q3 2022 | $37,926,000 | +23.1% | 796,089 | 0.0% | 4.07% | +43.0% |
Q2 2022 | $30,817,000 | -32.4% | 796,089 | 0.0% | 2.84% | -50.1% |
Q1 2022 | $45,616,000 | -28.1% | 796,089 | 0.0% | 5.69% | +0.2% |
Q4 2021 | $63,440,000 | -8.4% | 796,089 | 0.0% | 5.68% | -8.6% |
Q3 2021 | $69,268,000 | -32.4% | 796,089 | 0.0% | 6.22% | -12.9% |
Q2 2021 | $102,465,000 | +60.8% | 796,089 | 0.0% | 7.14% | +51.0% |
Q1 2021 | $63,719,000 | -30.8% | 796,089 | -29.4% | 4.73% | -38.9% |
Q4 2020 | $92,085,000 | +231.6% | 1,127,934 | 0.0% | 7.73% | +91.1% |
Q3 2020 | $27,770,000 | -12.1% | 1,127,934 | 0.0% | 4.04% | -27.8% |
Q2 2020 | $31,582,000 | +56.6% | 1,127,934 | +0.7% | 5.60% | +20.1% |
Q1 2020 | $20,170,000 | – | 1,120,535 | – | 4.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |